Ameritas Investment Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Hold
4,164
﹤0.01% 1674
2025
Q4
$110K Hold
4,164
﹤0.01% 1640
2025
Q3
$71.1K Sell
4,164
-1,452
-26% -$20.8K ﹤0.01% 1901
2025
Q2
$70.5K Hold
5,616
﹤0.01% 1969
2025
Q1
$66.9K Hold
5,616
﹤0.01% 1943
2024
Q4
$82.2K Hold
5,616
﹤0.01% 1897
2024
Q3
$70.5K Hold
5,616
﹤0.01% 1993
2024
Q2
$47.8K Hold
5,616
﹤0.01% 2160
2024
Q1
$59.1K Hold
5,616
﹤0.01% 2051
2023
Q4
$58.4K Buy
5,616
+1,208
+27% +$9.63K ﹤0.01% 2077
2023
Q3
$27.9K Hold
4,408
﹤0.01% 2387
2023
Q2
$38.1K Buy
+4,408
New +$39.5K ﹤0.01% 2207

Other funds holding ZYME

Ameritas Investment Partners's ZYME Position: Q1 2026 in Review

Ameritas Investment Partners held its Zymeworks (ZYME) position steady in Q1 2026 at 4,164 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Ameritas Investment Partners first reported a position in ZYME in Q2 2023 and has held it in 12 quarters since. The position peaked at $110K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Ameritas Investment Partners held 4,164 shares of Zymeworks worth $104K as of Q1 2026.
  • Ameritas Investment Partners left its Zymeworks share count unchanged in Q1 2026.
  • Zymeworks made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1674 holding.
  • Ameritas Investment Partners first reported a position in Zymeworks in Q2 2023 and has held it in 12 quarters since.
  • Ameritas Investment Partners's Zymeworks position peaked at $110K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.